Exelixis (EXEL) had the highest return between January 1, 2015 and August 31, 2015 by a large-cap US stock, returning 304.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Exelixis (EXEL) | 1/1/2015 - 8/31/2015 | 304.76% |
Netflix (NFLX) | 1/1/2015 - 8/31/2015 | 134.03% |
Neurocrine Biosciences (NBIX) | 1/1/2015 - 8/31/2015 | 105.31% |
Wayfair (W) | 1/1/2015 - 8/31/2015 | 86.59% |
Halozyme Therapeutics (HALO) | 1/1/2015 - 8/31/2015 | 78.71% |
Coca-Cola Consolidated (COKE) | 1/1/2015 - 8/31/2015 | 74.78% |
Repligen (RGEN) | 1/1/2015 - 8/31/2015 | 71.86% |
DexCom (DXCM) | 1/1/2015 - 8/31/2015 | 69.26% |
Corcept Therapeutics (CORT) | 1/1/2015 - 8/31/2015 | 66.11% |
TKO (TKO) | 1/1/2015 - 8/31/2015 | 64.18% |
Amazon (AMZN) | 1/1/2015 - 8/31/2015 | 64.08% |
Comfort Systems USA (FIX) | 1/1/2015 - 8/31/2015 | 62.87% |
Incyte (INCY) | 1/1/2015 - 8/31/2015 | 57.76% |
Insmed (INSM) | 1/1/2015 - 8/31/2015 | 56.07% |
Martin Marietta Materials (MLM) | 1/1/2015 - 8/31/2015 | 51.5% |
ICON (ICLR) | 1/1/2015 - 8/31/2015 | 50.89% |
Genmab A-S (GMAB) | 1/1/2015 - 8/31/2015 | 49.43% |
Paycom Software (PAYC) | 1/1/2015 - 8/31/2015 | 46.6% |
T-Mobile US (TMUS) | 1/1/2015 - 8/31/2015 | 46.16% |
Trip Group Ltd ADR (TCOM) | 1/1/2015 - 8/31/2015 | 44.46% |
Manhattan Associates (MANH) | 1/1/2015 - 8/31/2015 | 42.95% |
Biomarin Pharmaceutical (BMRN) | 1/1/2015 - 8/31/2015 | 41.65% |
Vulcan Materials (VMC) | 1/1/2015 - 8/31/2015 | 41.5% |
HubSpot (HUBS) | 1/1/2015 - 8/31/2015 | 39.42% |
Molina Healthcare (MOH) | 1/1/2015 - 8/31/2015 | 38.39% |
Large-cap stocks are treated as having a market cap of $10B+.